Proximal Deep Vein Thrombosis After Hip Replacement for Oncologic Indications

NATHAN, SAMINATHAN S.; Simmons, Kristy A.; Lin, Patrick P.; Morris, Carol D.; Athanasian, Edward A.; Boland, Patrick J.; Healey, John H.

doi:10.2106/00004623-200605000-00017

Cited by 19 publications

(25 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the current series, the overall PE rate during hospitalization was 0.3% (10 of 3750), which is relatively low compared with the rates in previous reports [2,4,13,16,18,20,22,27]. One possible reason for this is the lower reported incidence of PE in Japanese patients compared with white patients [11].…”

Section: Discussioncontrasting

confidence: 68%

Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery

Yasunaga

Horiguchi

Kawano

2013

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Background Limited information is available regarding the incidence, risk factors, and optimal prophylaxis in orthopaedic oncology patients, although malignancy and major orthopaedic surgery are associated with an increased pulmonary embolism (PE) risk. Questions/purposes We aimed to investigate the incidence of PE after musculoskeletal tumor surgery in Japanese patients and analyze the potential risk factors for PE.

show abstract

Section: Discussioncontrasting

confidence: 68%

Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery

Yasunaga

Horiguchi

Kawano

2013

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

show abstract

“…T he role of anticoagulation in the management of patients undergoing lower-extremity total joint arthroplasty has become more defined; however, its role in limb-salvage surgery remains unclear [1][2][3][4][5][6] . Included in limb-salvage surgical procedures is the use of oncologic endoprostheses ( Fig.…”

mentioning

confidence: 99%

Incidence of Symptomatic Venous Thromboembolism in Oncologic Patients Undergoing Lower-Extremity Endoprosthetic Arthroplasty

Ramo¹,

Griffin

Gill

et al. 2011

Journal of Bone and Joint Surgery

View full text Add to dashboard Cite

show abstract

“…There are few reports about postoperative VTE development in malignant bone and soft tissue tumors [10][11][12][13][14][15][16][17][18][19][20][21]. As large studies occasionally include patients receiving anticoagulant therapy or localization of the upper extremity, we cannot compare the postoperative VTE incidences and risk factors equally.…”

Section: Discussionmentioning

confidence: 99%

Incidence, Diagnosis, and Risk Factors of Venous Thromboembolism after Surgery for Malignant Bone and Soft Tissue Tumor of Lower Extremity

Yoshimura¹,

Ikegami²,

Aoki³

et al. 2018

Int J Phys Med Rehabil

View full text Add to dashboard Cite

Objective: This study aimed to prospectively evaluate the incidence, characteristics, and risk factors of venous thromboembolism (VTE) development, and the diagnostic value of blood coagulation markers in patients receiving surgery for malignant bone and soft tissue tumor of lower extremity. Methods:A prospective study of 20 patients who were examined using ultrasonography. Serum soluble fibrin monomer complex (SFMC) and D-dimer were measured in the perioperative period. VTE incidence, VTE development time, change in blood coagulation markers, and effect of each risk factor were evaluated.Results:VTE was found in 8 of 20 patients. Four of these 8 patients had the finding of pulmonary embolism (PE) without symptom. Onset time of VTE was from day 1 to 7 after surgery. The cutoff value of SFMC was <3 µg/mL at any measurement point and D-dimer was approximately 2 µg/mL in receiver operating characteristic analysis. Body mass index was the only significant risk factor. Conclusion: VTE showed high incidence and often occurred in the early period in only physical prophylaxis after surgery. SFMC or D-dimer was not always useful to detect VTE development. With regard to rehabilitation intervention, risk management is required until 1 week after surgery.

show abstract

Proximal Deep Vein Thrombosis After Hip Replacement for Oncologic Indications

Cited by 19 publications

References 23 publications

Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery

Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery

Incidence of Symptomatic Venous Thromboembolism in Oncologic Patients Undergoing Lower-Extremity Endoprosthetic Arthroplasty

Incidence, Diagnosis, and Risk Factors of Venous Thromboembolism after Surgery for Malignant Bone and Soft Tissue Tumor of Lower Extremity

Contact Info

Product

Resources

About